Literature DB >> 10024320

Heart rate and subsequent blood pressure in young adults: the CARDIA study.

J R Kim1, C I Kiefe, K Liu, O D Williams, D R Jacobs, A Oberman.   

Abstract

The objective of the present study was to examine the hypothesis that baseline heart rate (HR) predicts subsequent blood pressure (BP) independently of baseline BP. In the multicenter longitudinal Coronary Artery Risk Development in Young Adults study of black and white men and women initially aged 18 to 30 years, we studied 4762 participants who were not current users of antihypertensive drugs and had no history of heart problems at the baseline examination (1985-1986). In each race-sex subgroup, we estimated the effect of baseline HR on BP 2, 5, 7, and 10 years later by use of repeated measures regression analysis, adjusting for baseline BP, age, education, body fatness, physical fitness, fasting insulin, parental hypertension, cigarette smoking, alcohol consumption, oral contraceptive use, and change of body mass index from baseline. The association between baseline HR and subsequent systolic BP (SBP) was explained by multivariable adjustment. However, HR was an independent predictor of subsequent diastolic BP (DBP) regardless of initial BP and other confounders in white men, white women, and black men (0.7 mm Hg increase per 10 bpm). We incorporated the part of the association that was already present at baseline by not adjusting for baseline DBP: the mean increase in subsequent DBP was 1.3 mm Hg per 10 bpm in white men, white women, and black men. A high HR may be considered a risk factor for subsequent high DBP in young persons.

Entities:  

Mesh:

Year:  1999        PMID: 10024320     DOI: 10.1161/01.hyp.33.2.640

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  18 in total

Review 1.  The prognostic significance of heart rate for cardiovascular disease and hypertension.

Authors:  Trygve B Tjugen; Arnljot Flaa; Sverre E Kjeldsen
Journal:  Curr Hypertens Rep       Date:  2010-06       Impact factor: 5.369

2.  Stimulus response of blood pressure in black and white young individuals helps explain racial divergence in adult cardiovascular disease: the Bogalusa Heart Study.

Authors:  Gerald S Berenson; Wei Chen; Pronabesh Dasmahapatra; Camilo Fernandez; Thomas Giles; Jihua Xu; Sathanur R Srinivasan
Journal:  J Am Soc Hypertens       Date:  2011-04-13

Review 3.  Obstructive sleep apnea: the new cardiovascular disease. Part I: Obstructive sleep apnea and the pathogenesis of vascular disease.

Authors:  Rami Khayat; Brian Patt; Don Hayes
Journal:  Heart Fail Rev       Date:  2008-09-20       Impact factor: 4.214

Review 4.  The role of the kidney and the sympathetic nervous system in hypertension.

Authors:  Philip Thomas; Indranil Dasgupta
Journal:  Pediatr Nephrol       Date:  2014-03-08       Impact factor: 3.714

5.  Temporal Changes in Resting Heart Rate, Left Ventricular Dysfunction, Heart Failure and Cardiovascular Disease: CARDIA Study.

Authors:  Chike C Nwabuo; Duke Appiah; Henrique T Moreira; Henrique D Vasconcellos; Queen N Aghaji; Bharath Ambale-Venkatesh; Jamal S Rana; Norrina B Allen; Donald M Lloyd-Jones; Pamela J Schreiner; Samuel S Gidding; João A C Lima
Journal:  Am J Med       Date:  2020-01-27       Impact factor: 4.965

6.  Renal Sympathetic Denervation for Treatment of Hypertension.

Authors:  Eduardo Pimenta; Suzanne Oparil
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-02-01

Review 7.  Impact of increased heart rate on clinical outcomes in hypertension: implications for antihypertensive drug therapy.

Authors:  Paolo Palatini; Athanase Benetos; Stevo Julius
Journal:  Drugs       Date:  2006       Impact factor: 9.546

8.  Sex-specific impact of maternal-fetal risk factors on depression and cardiovascular risk 40 years later.

Authors:  J M Goldstein; S Cherkerzian; S L Buka; G Fitzmaurice; M Hornig; M Gillman; S O'Toole; R P Sloan
Journal:  J Dev Orig Health Dis       Date:  2011-12       Impact factor: 2.401

Review 9.  Drug Development for Hypertension: Do We Need Another Antihypertensive Agent for Resistant Hypertension?

Authors:  Eduardo Pimenta; David A Calhoun
Journal:  Curr Hypertens Rep       Date:  2016-04       Impact factor: 5.369

Review 10.  Percutaneous Delivery of Antihypertensive Agents: Advances and Challenges.

Authors:  Kevin Ita; Sharon Ashong
Journal:  AAPS PharmSciTech       Date:  2020-01-06       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.